AMI Labs

Founders, Backgrounds, and Bench

AMI Labs was founded in December 2025 by Turing Prize winner Yann LeCun, Alexandre LeBrun, Saining Xie, and Pascale Fung. LeCun serves as executive chairman, while LeBrun leads as CEO. The company maintains a research hub in Montreal led by Michael Rabbat.

Data Accuracy: GREEN -- Core facts (founding, team, funding round size, valuation, partnership) corroborated by multiple independent public sources including TechCrunch, Crunchbase, and Bloomberg.

Company Overview

AMI Labs is a Paris-based AI startup focused on building "world models" designed to understand and reason about the physical world. The company secured a $1.03 billion seed round in March 2026, co-led by Cathay Innovation, Greycroft, Hiro Capital, HV Capital, and Bezos Expeditions, at a reported $3.5 billion pre-money valuation. At the time of funding, the company employed approximately a dozen people. Its first publicly confirmed commercial partnership is with the French health-tech company Nabla.

Data Accuracy: GREEN -- Core facts (founding date, headquarters, seed round, valuation, key personnel) are confirmed by multiple independent public sources including TechCrunch, Bloomberg, and company statements.

The Product and the Stack

AMI Labs is developing world-model-based AI designed to process sensor data, maintain persistent memory, and perform reasoning and planning. This approach contrasts with large language models, aiming for applications in industrial automation, robotics, and healthcare. The business model is a technology licensing platform for industry partners. The company has one confirmed partnership with Nabla.

Data Accuracy: GREEN -- Core product claims and technical approach are confirmed by the company's website and multiple press reports. Partnership details are also publicly confirmed.

The Market They Are Entering

AMI Labs targets industrial automation, robotics, and healthcare. The global industrial automation and control systems market was valued at approximately $160 billion in 2024. The market for AI in healthcare is forecast to exceed $150 billion by 2028. Demand is driven by the need for predictive maintenance, flexible automation, and clinical reasoning support. Regulatory environments in healthcare and autonomous systems present both headwinds and potential catalysts for safety-focused AI.

Metric	Value
Industrial Automation & Control (2024)	$160B
AI in Healthcare (2028 forecast)	$150B

Data Accuracy: YELLOW -- Market sizing figures are from third-party analyst reports for adjacent sectors, not for "world model" AI specifically.

The Competitive Field

AMI Labs competes by pursuing a foundational research bet against the current LLM paradigm. Its primary edge is a combination of talent, capital, and research credibility.

Company	Positioning	Stage / Funding	Notable Differentiator
AMI Labs	Developer of "world-model" AI for real-world reasoning and control.	Seed; $1.03B raised at $3.5B valuation.	Foundational research focus on world models for sensor data.

Data Accuracy: GREEN -- Core funding, valuation, team, and strategic details are confirmed by multiple high-quality sources.

Opportunity

AMI Labs aims to become the foundational world-model layer for real-world AI applications. The $1.03 billion seed round provides the runway to attempt a platform-level outcome. Growth paths include platform licensing, vertical domination in healthcare, and research-to-product spinoffs.

Data Accuracy: YELLOW -- The opportunity analysis is based on the company's stated mission, funding round, and initial partnership, which are confirmed.